Literature DB >> 34175386

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.

S Rao1, M G Guren2, K Khan3, G Brown4, A G Renehan5, S E Steigen6, E Deutsch7, E Martinelli8, D Arnold9.   

Abstract

Entities:  

Keywords:  anal cancer; clinical practice guidelines; diagnosis; follow-up; treatment

Year:  2021        PMID： 34175386     DOI： 10.1016/j.annonc.2021.06.015

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Simultaneous and Spatially-Resolved Analysis of T-Lymphocytes, Macrophages and PD-L1 Immune Checkpoint in Rare Cancers.

Authors:  Karina Cereceda; Nicolas Bravo; Roddy Jorquera; Roxana González-Stegmaier; Franz Villarroel-Espíndola
Journal:  Cancers (Basel)       Date:  2022-06-06       Impact factor: 6.575

2.  Intensity-Modulated Radiotherapy Associated With Improved Survival Outcome in Anal Cancer.

Authors:  Ahmed Allam Mohamed; Marsha Schlenter; Alexander Heinzel; Svetlana Kintsler; Michael J Eble
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

3.  Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer.

Authors:  Christina Sauter; Jan C Peeken; Kai Borm; Christian Diehl; Stefan Münch; Stephanie E Combs; Hendrik Dapper
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

4.  A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer.

Authors:  Pierfrancesco Franco; Eva Segelov; Anders Johnsson; Rachel Riechelmann; Marianne G Guren; Prajnan Das; Sheela Rao; Dirk Arnold; Karen-Lise Garm Spindler; Eric Deutsch; Marco Krengli; Vincenzo Tombolini; David Sebag-Montefiore; Francesca De Felice
Journal:  Cancers (Basel)       Date:  2022-03-27       Impact factor: 6.639

5.  Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study.

Authors:  Eirik Malinen; Ane L Appelt; Stelios Theophanous; Per-Ivar Lønne; Ananya Choudhury; Maaike Berbee; Andre Dekker; Kristopher Dennis; Alice Dewdney; Maria Antonietta Gambacorta; Alexandra Gilbert; Marianne Grønlie Guren; Lois Holloway; Rashmi Jadon; Rohit Kochhar; Ahmed Allam Mohamed; Rebecca Muirhead; Oriol Parés; Lukasz Raszewski; Rajarshi Roy; Andrew Scarsbrook; David Sebag-Montefiore; Emiliano Spezi; Karen-Lise Garm Spindler; Baukelien van Triest; Vassilios Vassiliou; Leonard Wee
Journal:  Diagn Progn Res       Date:  2022-08-04

Review 6.  Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies.

Authors:  Maria Cecília Mathias-Machado; Renata D'Alpino Peixoto; Camila Motta Venchiarutti Moniz; Alexandre A Jácome
Journal:  Biomedicines       Date:  2022-08-20

7.  Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma.

Authors:  Stefano Kim; Jihane Boustani; Dewi Vernerey; Véronique Vendrely; Ludovic Evesque; Eric Francois; Laurent Quero; Francois Ghiringhelli; Christelle de la Fouchardière; Laëtitia Dahan; Oliver Bouché; Benoist Chibaudel; Farid El Hajbi; Chloé Vernet; Magali Rebucci-Peixoto; Alexandra Feuersinger; Christophe Maritaz; Christophe Borg
Journal:  Front Oncol       Date:  2022-08-24       Impact factor: 5.738

8.  A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).

Authors:  S Rao; G Anandappa; J Capdevila; L Dahan; L Evesque; S Kim; M P Saunders; D C Gilbert; L H Jensen; E Samalin; K-L Spindler; S Tamberi; A Demols; M G Guren; D Arnold; M Fakih; T Kayyal; M Cornfeld; C Tian; M Catlett; M Smith; J-P Spano
Journal:  ESMO Open       Date:  2022-07-08

9.  A Pattern of Care Report on the Management of Patients with Squamous Cell Carcinoma of the Anus-A Study by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Tumors Study Group.

Authors:  Pierfrancesco Franco; Giuditta Chiloiro; Giampaolo Montesi; Sabrina Montrone; Alessandra Arcelli; Tiziana Comito; Francesca Arcadipane; Luciana Caravatta; Gabriella Macchia; Marco Lupattelli; Marina Rita Niespolo; Fernando Munoz; Elisa Palazzari; Marco Krengli; Francesca Valvo; Maria Antonietta Gambacorta; Domenico Genovesi; Giovanna Mantello
Journal:  Medicina (Kaunas)       Date:  2021-12-09       Impact factor: 2.430

10.  Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.

Authors:  Pratik Adusumilli; Noha Elsayed; Stelios Theophanous; Robert Samuel; Rachel Cooper; Nathalie Casanova; Damien J Tolan; Alexandra Gilbert; Andrew F Scarsbrook
Journal:  Eur Radiol       Date:  2022-03-11       Impact factor: 7.034
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.